Medtronic ICD Growth Rate Hiccups On “Trialing” Of St. Jude Epic

Medtronic expects to quickly return to 20%-plus growth in its ICD business with the launch of its Insync Sentry cardiac resynchronization therapy defibrillator with thoracic fluid status monitoring